These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4646804)

  • 1. Biochemical effects of aromatic compounds. 3. Ferrihaemoglobinaemia and the presence of p-hydroxy-o-toluidine in human blood after the administration of prilocaine.
    Hjelm M; Ragnarsson B; Wistrand P
    Biochem Pharmacol; 1972 Nov; 21(21):2825-34. PubMed ID: 4646804
    [No Abstract]   [Full Text] [Related]  

  • 2. Hemoglobin adducts of the human bladder carcinogen o-toluidine after treatment with the local anesthetic prilocaine.
    Gaber K; Harréus UA; Matthias C; Kleinsasser NH; Richter E
    Toxicology; 2007 Jan; 229(1-2):157-64. PubMed ID: 17129655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of systemic o-toluidine after intrathecal administration of hyperbaric prilocaine in humans: a prospective cohort study.
    Guntz E; Carini A; Koslitz S; Brüning T; Kapessidou P; Weiss T
    Arch Toxicol; 2021 Mar; 95(3):925-934. PubMed ID: 33475793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimation of N-hydroxy-o-toluidine, a urinary metabolite of o-toluidine and o-nitrosotoluene, by high performance liquid chromatography with electrochemical detection.
    Kulkarni B; Fiala ES; Weisburger JH
    Carcinogenesis; 1983 Oct; 4(10):1275-9. PubMed ID: 6616755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of lidocaine, prilocaine and the prilocaine metabolite o-toluidine in plasma by high-performance liquid chromatography.
    Klein J; Fernandes D; Gazarian M; Kent G; Koren G
    J Chromatogr B Biomed Appl; 1994 Apr; 655(1):83-8. PubMed ID: 8061836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metabolic studies following prilocaine anesthesia].
    Struck H; Matthes H; Pakusa W
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jul; 2(3):269-72. PubMed ID: 4902020
    [No Abstract]   [Full Text] [Related]  

  • 7. Polyacrylonitrile / graphene oxide nanofibers for packed sorbent microextraction of drugs and their metabolites from human plasma samples.
    Karimiyan H; Uheida A; Hadjmohammadi M; Moein MM; Abdel-Rehim M
    Talanta; 2019 Aug; 201():474-479. PubMed ID: 31122453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Qualitative and quantitative influences of ortho chlorine substituents on the microsomal metabolism of 4-toluidines.
    Tyrakowska B; Boeren S; Geurtsen B; Rietjens IM
    Drug Metab Dispos; 1993; 21(3):508-19. PubMed ID: 8100509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the medicines lidocaine, prilocaine, and their metabolites, 2,6-dimethylaniline and 2-methylaniline, for DNA adduct formation in rat tissues.
    Duan JD; Jeffrey AM; Williams GM
    Drug Metab Dispos; 2008 Aug; 36(8):1470-5. PubMed ID: 18490435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disposition of clonixin (2-(3-chloro-o-toluidino) nicotinic acid) in humans.
    Katchen B; Buxbaum S; Ning J
    J Pharmacol Exp Ther; 1973 Oct; 187(1):152-7. PubMed ID: 4200989
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification and quantitative determination of aniline and toluidines in human urine.
    el-Bayoumy K; Donahue JM; Hecht SS; Hoffmann D
    Cancer Res; 1986 Dec; 46(12 Pt 1):6064-7. PubMed ID: 3779628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of o-toluidine kinetics].
    Zaĭtseva NV; Ulanova TS; Nurislamova TV; Karnazhitskaia TD; Gimervert DA
    Gig Sanit; 1997; (5):36-8. PubMed ID: 9378345
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoarylamines in the general population--a cross-sectional population-based study including 1004 Bavarian subjects.
    Kütting B; Göen T; Schwegler U; Fromme H; Uter W; Angerer J; Drexler H
    Int J Hyg Environ Health; 2009 May; 212(3):298-309. PubMed ID: 18789761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess.
    Ward EM; Sabbioni G; DeBord DG; Teass AW; Brown KK; Talaska GG; Roberts DR; Ruder AM; Streicher RP
    J Natl Cancer Inst; 1996 Aug; 88(15):1046-52. PubMed ID: 8683635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and clinical pharmacological studies with mepivacaine and prilocaine.
    Arthur GR; Scott DH; Boyes RN; Scott DB
    Br J Anaesth; 1979 Jun; 51(6):481-5. PubMed ID: 380609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prilocaine as an hypotensive ocular agent (author's transl)].
    Arbex ST; Neder AC; de Mattos Filho TR; Ramos AO
    Rev Bras Pesqui Med Biol; 1979 Apr; 12(1):1-6. PubMed ID: 461853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of prilocaine gels for enhanced local anesthetic action.
    Kang C; Shin SC
    Arch Pharm Res; 2012 Jul; 35(7):1197-204. PubMed ID: 22864742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Penile absorption of EMLA cream in piglets: implications for use of EMLA in neonatal circumcision.
    Gazarian M; Taddio A; Klein J; Kent G; Koren G
    Biol Neonate; 1995; 68(5):334-41. PubMed ID: 8835088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prilocaine- and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation.
    Higuchi R; Fukami T; Nakajima M; Yokoi T
    Drug Metab Dispos; 2013 Jun; 41(6):1220-30. PubMed ID: 23530020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecificity of the enzymatic biotransformation of the enantiomers of prilocaine (Citanest).
    Akerman B; Ross S
    Acta Pharmacol Toxicol (Copenh); 1970; 28(6):445-53. PubMed ID: 5536778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.